Costly treatments from Merck & Co and other drugmakers, and a vaccine from Sanofi, are on the horizon. But growing numbers of gastroenterologists are more excited about the use of human stool ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PHILADELPHIA -- ...

Clostridium difficile infection is one of the most common healthcare-associated infections in adults in the United States. Older Americans are especially vulnerable to CDI, 2 and this infection has ...

Researchers at Vanderbilt University Medical Center have obtained the crystal structure of a toxin from the bacterium Clostridium difficile ("C. diff")—the leading cause of hospital-acquired diarrhea ...

There are several risk factors healthcare providers can identify upon patient admission to predict asymptomatic Clostridium difficile colonization, according to a study published in the American ...

A new article details a research breakthrough that provides a promising starting point for scientists to create drugs that can cure C. diff -- a virulent health care-associated infection that causes ...

Dear Dr. Roach: I had two previous episodes of C. diff and was treated with vancomycin. My stool tests the first time were negative. Recently, I got the same symptoms, and the doctor did a stool test ...

Therefore, a two-step diagnostic algorithm with a rapid highly sensitive screening method to identify positive samples, to be confirmed by gold standard, should be strongly recommended. Some ...

A new study, led by researchers from the University of California, Irvine (UCI), uncovers the long-sought-after, three-dimensional structure of a toxin primarily responsible for devastating ...

Researchers have obtained the crystal structure of a toxin from the bacterium Clostridium difficile ('C. diff') -- the leading cause of hospital-acquired diarrhea in the United States. They also found ...